Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bryn Russell"'
Autor:
Amy Hawarden, Marcus Price, Bryn Russell, Godfrey Wilson, Laura Farrelly, Andrew Embleton-Thirsk, Mahesh Parmar, Richard Edmondson
Publikováno v:
PLoS ONE, Vol 18, Iss 3, p e0281798 (2023)
IntroductionFor patients with advanced epithelial ovarian cancer, complete surgical cytoreduction remains the strongest predictor of outcome. However, identifying patients who are likely to benefit from such surgery remains elusive and to date few su
Externí odkaz:
https://doaj.org/article/d646f72f4c2246529a8550dd57df5393
Autor:
Amy Hawarden, Bryn Russell, Mary Ellen Gee, Fatima Skayali, Andrew Clamp, Emma Jayne Crosbie, Richard John Edmondson
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Despite improvements in median survival some patients with advanced ovarian cancer die within 100 days of diagnosis; the reasons for which remain poorly understood. Here we investigate if ultra short-term survival can be explained
Externí odkaz:
https://doaj.org/article/f5986f788d314232a32522982a00b82c
Autor:
Amy Hawarden, Bryn Russell, Mary Ellen Gee, Fatima Kayali, Andrew Clamp, Emma Jayne Crosbie, Richard John Edmondson
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/e436520ea1684fdcacd5c9f6056b8a5e
Autor:
Thomas D. J. Walker, Zahra F. Faraahi, Marcus J. Price, Amy Hawarden, Caitlin A. Waddell, Bryn Russell, Dominique M. Jones, Aiste McCormick, N. Gavrielides, S. Tyagi, Laura C. Woodhouse, Bethany Whalley, Connor Roberts, Emma J. Crosbie, Richard J. Edmondson
Publikováno v:
Walker, T D J, Faraahi, Z F, Price, M J, Hawarden, A, Waddell, C A, Russell, B, Jones, D M, McCormick, A, Gavrielides, N, Tyagi, S, Woodhouse, L C, Whalley, B, Roberts, C, Crosbie, E J & Edmondson, R J 2023, ' The DNA damage response in advanced ovarian cancer: functional analysis combined with machine learning identifies signatures that correlate with chemotherapy sensitivity and patient outcome ', British Journal of Cancer . https://doi.org/10.1038/s41416-023-02168-3
Background Ovarian cancers are hallmarked by chromosomal instability. New therapies deliver improved patient outcomes in relevant phenotypes, however therapy resistance and poor long-term survival signal requirements for better patient preselection.
Autor:
Kathryn Baxter, Bryn Russell, Amy Hawarden, Mary Gee, Nardeen Khalil, Dominique Jones, Vanitha Sivalingam, Richard Edmondson
Objective The role of surgery for patients with advanced ovarian cancer is well established but wide variations in the percentage of patients undergoing surgery exist. Design Observational Study Setting The 19 cancer alliances in England, UK Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::547f0ae268b90356b0bcd17509b1ded5
https://doi.org/10.22541/au.165470405.53192773/v1
https://doi.org/10.22541/au.165470405.53192773/v1